K
Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Headquartered in Montreal, Knight has operations in Canada and in 10 countries in Latin America and has over 700 employees globally. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD.
Investor insights
Funding rounds participated in
$39M sweet spot round size
Investor type
Public Company
Basic info
Industry
Pharmaceutical Manufacturing
Sectors
Pharmaceutical Manufacturing
Date founded
2014
Funding rounds raised
Total raised
$39M
from 1 investors over 1 rounds
K
Knight Therapeutics raised $39M on January 23, 2023
Investors: International Finance Corporation